Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $28.12, but opened at $26.59. Chugai Pharmaceutical shares last traded at $27.48, with a volume of 11,249 shares trading hands.
Chugai Pharmaceutical Stock Performance
The company has a market cap of $90.32 billion, a price-to-earnings ratio of 34.31 and a beta of 0.63. The company’s 50 day moving average price is $26.70 and its 200 day moving average price is $24.37.
About Chugai Pharmaceutical
Chugai Pharmaceutical Co, Ltd. is a Japan-based biopharmaceutical company headquartered in Tokyo that focuses on the discovery, development, manufacture and marketing of prescription medicines. The company develops both biologics and small-molecule therapies, with particular emphasis on oncology and immunology as well as treatments for bone and metabolic disorders. Chugai’s activities span the full drug lifecycle from early research and clinical development through regulatory approval, manufacturing and post-marketing support.
Chugai is known for its research-driven approach and its work on monoclonal antibodies and other biologic therapeutics.
Featured Stories
- Five stocks we like better than Chugai Pharmaceutical
- Your Signature Is Missing – Act Before It’s Too Late
- This coin has everything going for it
- What Expenses Can Be Deducted From Capital Gains Tax?
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
Receive News & Ratings for Chugai Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
